-
学术合作
CTONG共建NGS实验室的首家合作伙伴 -
检测平台
占全球测序市场份额80%的IIIumina在中国的临床肿瘤战略合作伙伴，与IIIumina启动Miseq dx测序仪联合临床实验 -
分子诊断解决方案
燃石医学将在中国开发基于Agilent SureSelect 靶向序列捕获系统的肿瘤基因检测，为中国肿瘤患者提供更多高品质的基于二代基因测序的分子诊断解决方案 -
学术合作
搭建分享、讨论真实世界精准诊疗病例的平台，共同探索未知，推进精准诊疗实践。 -
学术合作
CSCO CAGC肺癌研究指定检测合作伙伴 -
分子诊断解决方案
凯杰（QIAGEN）中国在液体活检领域战略合作伙伴，保证燃石ctDNA样本制备技术和产品质量的可靠 -
精准用药
阿斯利康肺癌NGS检测唯一战略伙伴，代表NGS方法学参与ASTRIS研究，参与L-moca奥拉帕利中国四期临床研究(HRD）
.png)
-
Academic Cooperation
CTONG's First Partner for Founding NGS Lab -
Detection Platform
Burning Rock and America illumina Co. (NASDDAQ: ILMN) declared a strategic cooperation in Guangzhou and San Diego officially and signed an agreement on jointly developing a tumor individualistic medical gene detection. -
Molecular Diagnostics Solutions
Burning Rock Dx is planning to develop genetic cancer testing based on the Agilent SureSelect targeting sequence capture system in China to provide more high-quality NGS-based molecular diagnostics solutions for Chinese cancer patients -
Academic Cooperation
For building a platform for sharing and discussing precision diagnosis and treatment cases in real world, probing into the unknown and promoting precision diagnosis and treatment practice. -
Academic Cooperation
Designated testing partner to CSCO and CAGC in lung cancer research -
Molecular Diagnostics Solutions
Burning Rock’s reassuring strategic partner in liquid biopsy - QIAGEN China with ctDNA sample preparation technology and high product quality -
Precision Medicine
AstraZeneca's sole strategic NGS lung cancer testing partner involved in ASTRIS research and L-moca Olaparib stage-IV clinical research (HRD) in China